Back to search

Canada· CA-DIN-02417510

NASACORT ALLERGY 24HR

A triamcinolone product containing triamcinolone acetonide, registered in Canada by SANOFI CONSUMER HEALTH INC. The same ATC class is registered in 11 of our 19 countries.

ATC R01AD11

Checked against Health Canada Drug Product Database (Canada) on

Informational only — not a medical device.

SOURCE REGISTER · CAHealth Canada Drug Product Database (Ca…normalisedNASACORT ALLERGY 24HRATCR01AD11REGISTER NO.CA-DIN-02417510PACKS LISTED0CHECKEDOctober 1, 2026

Where it is registered

Triamcinolone is registered in 11 of 19 countries.

Countries holding a registration under ATC R01AD11 (triamcinolone), each read from that country’s own register.

  • This record: Canada, from Health Canada Drug Product Database (Canada)
  • 6 of them publish a price we can compare per daily dose

Triamcinolone · ATC R01AD11

11 / 19 countries

  • Belgiumprice
  • Canada
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Switzerlandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Health Canada Drug Product Database (Canada)
Active substance
TRIAMCINOLONE ACETONIDE
Manufacturer
SANOFI CONSUMER HEALTH INC
Country
Canada (CA)
ATC code
R01AD11
ATC class
Triamcinolone
Defined daily dose
0.22 mg, N
Reimbursed
Not published by this register
Source register
Health Canada Drug Product Database (Canada)
Last checked
October 1, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

38 interactions on record for triamcinolone.

Graded by severity as the source publishes them — 38 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Triamcinolone · interactions on record

38 records

  • 38 moderate

Most severe, free to view

  • MiconazoleA07AC01moderate
  • LonafarnibA16AX20moderate
  • VoxelotorB06AX03moderate
  • ConivaptanC03XA02moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Triamcinolone in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All triamcinolone products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

  • Austria · Volon, Volon A
  • Belgium · Delphi, Kenacort-A
  • Cyprus · Triacort
  • Czechia · Triamcinolon Léčiva
  • Germany · Nasacort, Rhinisan
  • Denmark · Kenalog, Triamcinolone Acetonide Medipha
  • Estonia · Kenalog
  • Spain · Nasacort
  • Finland · Nasacort, Triamcinolone Medipha
  • France · Kenacort Retard, Nasacort
  • United Kingdom (Northern Ireland) · Nasacort
  • Greece · Jiven, Nasacort
  • Croatia · Kenalog
  • Hungary · Ftorocort, Kenalog
  • Ireland · Nasacort, Nasacort Allergy
  • Iceland · Kenacort-T, Nasacort
  • Italy · Kenacort, Nasacort
  • Lithuania · Ftorocort, Kenalog
  • Luxembourg · Delphi, Kenacort-A
  • Latvia · Ftorocort, Kenalog
  • Malta · Nasacort, Nasacort Allergy
  • Netherlands · Cremor Triamcinolonacetonide, Kenacort-A 10
  • Norway · Kenacort-T, Nasacort
  • Poland · Polcortolon
  • Portugal · Nasacort, Telfast Spray Nasal
  • Sweden · Kenacort-T, Nasacort
  • Slovenia · Kenalog
  • Slovakia · Triamcinolon Crm Léčiva, Triamcinolon Ung Léčiva

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f1d0b88c-7aae-45bd-af8d-e3388bd0d8f7
GET /v1/drugs/f1d0b88c-7aae-45bd-af8d-e3388bd0d8f7?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "din": "02417510",
  "form": "SPRAY, METERED DOSE",
  "class": "Human",
  "routes": [
    "NASAL"
  ],
  "source": "health_canada_dpd",
  "status": "MARKETED",
  "atc_raw": "R01AD11",
  "schedule": [
    "OTC"
  ],
  "drug_code": "90220",
  "strengths": [
    "55 MCG"
  ],
  "ahfs_class": null,
  "substances": [
    "TRIAMCINOLONE ACETONIDE"
  ],
  "product_categorization": null
}

See everything about triamcinolone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.